Cell- and Tissue-Based Therapy
"Cell- and Tissue-Based Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.
Descriptor ID |
D064987
|
MeSH Number(s) |
E02.095.147
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cell- and Tissue-Based Therapy".
Below are MeSH descriptors whose meaning is more specific than "Cell- and Tissue-Based Therapy".
This graph shows the total number of publications written about "Cell- and Tissue-Based Therapy" by people in this website by year, and whether "Cell- and Tissue-Based Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2007 | 1 | 1 | 2 |
2008 | 3 | 1 | 4 |
2009 | 1 | 0 | 1 |
2010 | 6 | 1 | 7 |
2011 | 5 | 1 | 6 |
2012 | 3 | 4 | 7 |
2013 | 5 | 6 | 11 |
2014 | 8 | 3 | 11 |
2015 | 6 | 3 | 9 |
2016 | 6 | 3 | 9 |
2017 | 6 | 5 | 11 |
2018 | 8 | 8 | 16 |
2019 | 7 | 1 | 8 |
2020 | 8 | 10 | 18 |
2021 | 4 | 8 | 12 |
2022 | 2 | 12 | 14 |
2023 | 2 | 21 | 23 |
2024 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell- and Tissue-Based Therapy" by people in Profiles.
-
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T?cell responses that potentiate cell therapy for fibrolamellar carcinoma. Cell Rep Med. 2024 Mar 19; 5(3):101469.
-
Pushing the CART to the Finish Line: Integrating Radiation Therapy Into Chimeric Antigen Receptor T-Cell Therapy Programs to Improve Outcomes for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Int J Radiat Oncol Biol Phys. 2024 Apr 01; 118(5):1152-1158.
-
Cell-Based Therapies for Rotator Cuff Injuries: An Updated Review of the Literature. Int J Mol Sci. 2024 Mar 08; 25(6).
-
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. J Immunother Cancer. 2024 Feb 29; 12(2).
-
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nat Med. 2024 Feb; 30(2):338-341.
-
Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. J Immunother Cancer. 2024 01 09; 12(1).
-
Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay. Front Immunol. 2023; 14:1299512.
-
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy. J Hematol Oncol. 2023 10 25; 16(1):108.
-
Clinical Pharmacology Profile of AMG?119, the First Chimeric Antigen Receptor?T (CAR-T) Cell Therapy Targeting Delta-Like Ligand?3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC). J Clin Pharmacol. 2024 Mar; 64(3):362-370.
-
Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma. J Immunol. 2023 10 01; 211(7):1067-1072.